Tate & Lyle (TATE) PT Lowered to GBX 700
Tate & Lyle (LON:TATE) had its price objective lowered by Jefferies Financial Group from GBX 725 ($9.47) to GBX 700 ($9.15) in a research report released on Tuesday, ThisIsMoney.Co.Uk reports. The brokerage currently has a hold rating on the stock.
Other analysts have also recently issued research reports about the company. Liberum Capital reissued a buy rating on shares of Tate & Lyle in a report on Thursday, February 7th. Deutsche Bank reissued a hold rating and set a GBX 675 ($8.82) price objective on shares of Tate & Lyle in a report on Monday, February 11th. Goldman Sachs Group increased their price objective on Tate & Lyle from GBX 700 ($9.15) to GBX 720 ($9.41) and gave the stock a neutral rating in a report on Friday, February 8th. Shore Capital reissued a hold rating on shares of Tate & Lyle in a report on Tuesday, March 26th. Finally, Barclays began coverage on Tate & Lyle in a report on Tuesday, March 19th. They set an overweight rating and a GBX 800 ($10.45) price objective on the stock. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the stock. Tate & Lyle presently has a consensus rating of Hold and an average target price of GBX 712 ($9.30).
Shares of TATE opened at GBX 727.80 ($9.51) on Tuesday. The stock has a market cap of $3.37 billion and a P/E ratio of 15.32. The company has a debt-to-equity ratio of 42.56, a quick ratio of 1.29 and a current ratio of 2.23. Tate & Lyle has a 52-week low of GBX 548.80 ($7.17) and a 52-week high of GBX 738.40 ($9.65).
Tate & Lyle PLC, together with its subsidiaries, provides ingredients and solutions to the food, beverage, and other industries in the United States, the United Kingdom, other European countries, and internationally. It operates through three segments: Food & Beverage Solutions, Sucralose, and Primary Products.
Recommended Story: What is the Current Ratio?
Receive News & Ratings for Tate & Lyle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tate & Lyle and related companies with MarketBeat.com's FREE daily email newsletter.